CDC: FDA tweaks flu vaccine after moderate to severe flu season CDC: A new bird flu may make the rounds this fall First FDA, now FTC to review homeopathics GoJo makes commitment to antibiotic stewardship Contract manufacturing to get a big boost from biosimilar approvals Aurobindo Pharma submits for tentative approval of new HIV medicine Actavis’ Namenda IR must remain on market, appeals court rules Boehringer Ingelheim’s Stiolto Respimat gets FDA approval Mylan will not make profit forecasts while considering Perrigo acquisition U.K.'s CMA still weighing in on RB acquisition of K-Y First Previous 64 65 66 67 68 Next Last
